14 articles for MR Tremblay
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-¿ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.
Infinity Pharmaceuticals
Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.
Infinity Pharmaceuticals
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
Infinity Pharmaceuticals
Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.
Chuq-Pavillon Chul and Université
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.
University of Texas
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R.
University of Texas Md Anderson Cancer Center
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M
Baylor College of Medicine
Chemotype-selective modes of action of ¿-opioid receptor agonists.
University of North Carolina